These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33452680)

  • 21. Histomorphometric changes following treatment for osteoporosis.
    Moreira CA; Dempster DW
    J Endocrinol Invest; 2017 Sep; 40(9):895-897. PubMed ID: 28550463
    [No Abstract]   [Full Text] [Related]  

  • 22. The tissue pathologic features of metabolic bone disease.
    Vigorita VJ
    Orthop Clin North Am; 1984 Oct; 15(4):613-29. PubMed ID: 6493734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
    Luo D; Ren H; Li T; Lian K; Lin D
    Osteoporos Int; 2016 Mar; 27(3):1093-1101. PubMed ID: 26395886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review.
    Reid IR; Sharma S; Kalluru R; Eagleton C
    Calcif Tissue Int; 2016 Sep; 99(3):322-5. PubMed ID: 27193832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
    Nollet M; Santucci-Darmanin S; Breuil V; Al-Sahlanee R; Cros C; Topi M; Momier D; Samson M; Pagnotta S; Cailleteau L; Battaglia S; Farlay D; Dacquin R; Barois N; Jurdic P; Boivin G; Heymann D; Lafont F; Lu SS; Dempster DW; Carle GF; Pierrefite-Carle V
    Autophagy; 2014; 10(11):1965-77. PubMed ID: 25484092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paget's disease of bone: an osteoimmunological disorder?
    Numan MS; Amiable N; Brown JP; Michou L
    Drug Des Devel Ther; 2015; 9():4695-707. PubMed ID: 26316708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of bone remodelling surfaces and bone structure in Paget's disease following long-term treatment with calcitonin.
    Delling GR; Schulz A; Ziegler R
    Calcif Tissue Res; 1977 May; 22 Suppl():359-61. PubMed ID: 912546
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological agents and natural compounds: available treatments for osteoporosis.
    Martiniakova M; Babikova M; Omelka R
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting subchondral bone for treating osteoarthritis: what is the evidence?
    Kwan Tat S; Lajeunesse D; Pelletier JP; Martel-Pelletier J
    Best Pract Res Clin Rheumatol; 2010 Feb; 24(1):51-70. PubMed ID: 20129200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paget's disease of bone.
    Appelman-Dijkstra NM; Papapoulos SE
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):657-668. PubMed ID: 30449547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying Potential Therapeutics for Osteoporosis by Exploiting the Relationship between Mevalonate Pathway and Bone Metabolism.
    Hasan WNW; Chin KY; Jolly JJ; Ghafar NA; Soelaiman IN
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):450-457. PubMed ID: 29683099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular aspects of reorganization of pagetic bone tissue].
    Rebel A; Basle MF
    Ann Biol Clin (Paris); 1985; 43(5):779-85. PubMed ID: 3911828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paget's disease].
    Renier JC
    Presse Med; 1986 Jun; 15(25):1175-7. PubMed ID: 2942924
    [No Abstract]   [Full Text] [Related]  

  • 36. [Structure and ultrastructure of osteoblasts and of the osteoid tissue in Paget's disease of bone (author's transl)].
    Basle M; Minard MF; Rebel A
    Pathol Biol (Paris); 1978 Nov; 26(8):475-9. PubMed ID: 370741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energy Metabolism of Bone.
    Motyl KJ; Guntur AR; Carvalho AL; Rosen CJ
    Toxicol Pathol; 2017 Oct; 45(7):887-893. PubMed ID: 29096593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
    Bagi CM; Volberg M; Moalli M; Shen V; Olson E; Hanson N; Berryman E; Andresen CJ
    Anat Rec (Hoboken); 2007 Aug; 290(8):1005-16. PubMed ID: 17610276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paget's disease of bone: recent advances in therapy.
    Canalis EM; Mundy GR; Raisz LG
    Conn Med; 1977 Feb; 41(2):79-83. PubMed ID: 138526
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of fluoride on 45Ca kinetics in Paget's disease.
    Lukert BP; Bolinger RE; Meek JC
    J Clin Endocrinol Metab; 1972 Sep; 35(3):387-91. PubMed ID: 5051361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.